AAPL   366.81 (+0.74%)
MSFT   207.13 (+1.19%)
FB   235.07 (-1.04%)
GOOGL   1,457.04 (+1.04%)
AMZN   2,904.60 (+0.90%)
NVDA   386.70 (+1.44%)
CGC   16.39 (-0.49%)
BABA   220.65 (+2.18%)
MU   49.71 (+0.02%)
GE   6.86 (+1.78%)
TSLA   1,188.20 (+6.12%)
AMD   52.35 (-0.44%)
T   30.14 (+0.77%)
ACB   12.02 (-2.04%)
F   6.04 (+1.00%)
GILD   76.05 (-0.01%)
DIS   112.37 (-0.58%)
BAC   23.44 (+0.73%)
NFLX   479.77 (-1.21%)
BA   181.03 (+0.39%)
AAPL   366.81 (+0.74%)
MSFT   207.13 (+1.19%)
FB   235.07 (-1.04%)
GOOGL   1,457.04 (+1.04%)
AMZN   2,904.60 (+0.90%)
NVDA   386.70 (+1.44%)
CGC   16.39 (-0.49%)
BABA   220.65 (+2.18%)
MU   49.71 (+0.02%)
GE   6.86 (+1.78%)
TSLA   1,188.20 (+6.12%)
AMD   52.35 (-0.44%)
T   30.14 (+0.77%)
ACB   12.02 (-2.04%)
F   6.04 (+1.00%)
GILD   76.05 (-0.01%)
DIS   112.37 (-0.58%)
BAC   23.44 (+0.73%)
NFLX   479.77 (-1.21%)
BA   181.03 (+0.39%)
AAPL   366.81 (+0.74%)
MSFT   207.13 (+1.19%)
FB   235.07 (-1.04%)
GOOGL   1,457.04 (+1.04%)
AMZN   2,904.60 (+0.90%)
NVDA   386.70 (+1.44%)
CGC   16.39 (-0.49%)
BABA   220.65 (+2.18%)
MU   49.71 (+0.02%)
GE   6.86 (+1.78%)
TSLA   1,188.20 (+6.12%)
AMD   52.35 (-0.44%)
T   30.14 (+0.77%)
ACB   12.02 (-2.04%)
F   6.04 (+1.00%)
GILD   76.05 (-0.01%)
DIS   112.37 (-0.58%)
BAC   23.44 (+0.73%)
NFLX   479.77 (-1.21%)
BA   181.03 (+0.39%)
AAPL   366.81 (+0.74%)
MSFT   207.13 (+1.19%)
FB   235.07 (-1.04%)
GOOGL   1,457.04 (+1.04%)
AMZN   2,904.60 (+0.90%)
NVDA   386.70 (+1.44%)
CGC   16.39 (-0.49%)
BABA   220.65 (+2.18%)
MU   49.71 (+0.02%)
GE   6.86 (+1.78%)
TSLA   1,188.20 (+6.12%)
AMD   52.35 (-0.44%)
T   30.14 (+0.77%)
ACB   12.02 (-2.04%)
F   6.04 (+1.00%)
GILD   76.05 (-0.01%)
DIS   112.37 (-0.58%)
BAC   23.44 (+0.73%)
NFLX   479.77 (-1.21%)
BA   181.03 (+0.39%)
Log in

CVE:RLVRelevium Technologies Stock Price, Forecast & News

C$0.03
0.00 (0.00 %)
(As of 07/2/2020 11:11 AM ET)
Add
Compare
Today's Range
C$0.03
Now: C$0.03
C$0.03
50-Day Range
C$0.03
MA: C$0.04
C$0.05
52-Week Range
C$0.01
Now: C$0.03
C$0.09
Volume87,250 shs
Average Volume979,787 shs
Market CapitalizationC$5.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Relevium Technologies Inc. engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and nutri cosmeceuticals primarily through its Bioganix brand portfolio online, as well as dietary supplements under the LeefyLyfe brand name through its wholesale, retail, and online distribution channels. It is also involved in the extraction, formulation, development, and encapsulation of proprietary nutraceutical products for medical purposes. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. The company was incorporated in 2012 and is headquartered in Montreal, Canada. Relevium Technologies Inc. is a subsidiary of iTech Medical, Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-514-8248559

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$4.20 million
Cash FlowC$0.00 per share
Book ValueC$0.03 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$5.97 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RLV News and Ratings via Email

Sign-up to receive the latest news and ratings for RLV and its competitors with MarketBeat's FREE daily newsletter.

Relevium Technologies (CVE:RLV) Frequently Asked Questions

How has Relevium Technologies' stock been impacted by COVID-19 (Coronavirus)?

Relevium Technologies' stock was trading at C$0.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RLV shares have increased by 100.0% and is now trading at C$0.03. View which stocks have been most impacted by Coronavirus.

Has Relevium Technologies been receiving favorable news coverage?

Headlines about RLV stock have been trending very negative recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Relevium Technologies earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Relevium Technologies.

Who are some of Relevium Technologies' key competitors?

What other stocks do shareholders of Relevium Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Canopy Growth (CGC), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), 1933 Industries (TGIF), Acquired Sales (AQSP), Aphria (APHA), Aphria (APHA) and Aldeyra Therapeutics (ALDX).

Who are Relevium Technologies' key executives?

Relevium Technologies' management team includes the following people:
  • Mr. Aurelio Useche C.M.A., M.B.A., Pres, CEO & Director (Age 51)
  • Mr. Edward Ierfino, Mang. of Investor Relations (Age 51)
  • Mr. Wayne D. Cockburn, Consultant (Age 62)
  • Mr. Faycal Salek, Chief Financial Officer
  • Mr. Abis Hussain, Sr. Marketing Officer

What is Relevium Technologies' stock symbol?

Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."

How do I buy shares of Relevium Technologies?

Shares of RLV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Relevium Technologies' stock price today?

One share of RLV stock can currently be purchased for approximately C$0.03.

How big of a company is Relevium Technologies?

Relevium Technologies has a market capitalization of C$5.97 million and generates C$4.20 million in revenue each year.

What is Relevium Technologies' official website?

The official website for Relevium Technologies is www.releviumcorp.com.

How can I contact Relevium Technologies?

Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.